{"id":"NCT00856297","sponsor":"Novartis Vaccines","briefTitle":"Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine","officialTitle":"An Open-Label, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Adolescents Who Previously Received Novartis MenACWY Conjugate Vaccine or Commercially Available MenACWY Conjugate Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2012-11","completion":"2012-11","firstPosted":"2009-03-05","resultsPosted":"2014-01-22","lastUpdate":"2017-06-14"},"enrollment":389,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Meningitis"],"interventions":[{"type":"BIOLOGICAL","name":"MenACWY-CRM conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Licensed comparator","otherNames":["Quadrivalent meningococcal conjugate vaccine with diphtheria toxoid as the protein carrier"]}],"arms":[{"label":"MenACWY-CRM","type":"EXPERIMENTAL"},{"label":"Licensed comparator","type":"ACTIVE_COMPARATOR"},{"label":"Naive","type":"OTHER"},{"label":"MenACWY-CRM/MenACWY-CRM","type":"EXPERIMENTAL"},{"label":"Licensed comparator/MenACWY-CRM","type":"EXPERIMENTAL"}],"summary":"The primary objective is to evaluate the persistence of bactericidal antibodies in adolescents previously enrolled in the V59P13 study who received either Novartis MenACWY Conjugate Vaccine or commercially available MenACWY conjugate vaccine. The study will also enroll age-matched subjects who have never received any other meningococcal vaccine (naïve subjects) to serve as an additional control group.","primaryOutcome":{"measure":"Percentages of Subjects With Human Complement Serum Bactericidal Activity (hSBA) Titers≥ 1:8, After One Dose of Either MenACWY-CRM Conjugate or Licensed Comparator Vaccine","timeFrame":"21 months, 3 years and 5 years postvaccination","effectByArm":[{"arm":"MenACWY-CRM","deltaMin":44,"sd":null},{"arm":"Licensed Comparator","deltaMin":27,"sd":null}],"pValues":[]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":32,"countries":["United States"]},"refs":{"pmids":["21339701"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":284},"commonTop":["Injection site pain","Myalgia","Headache","Nausea","Injection site erythema"]}}